Related Experiment Video
Updated: Apr 17, 2026
Homemade Site Directed Mutagenesis of Whole Plasmids
Published on: May 11, 2009
Mycoplasma pneumoniae and Chlamydia spp. infection in community-acquired pneumonia, Germany, 2011-2012
Abstract:
Mycoplasma pneumoniae and Chlamydia spp., which are associated with community-acquired pneumonia (CAP), are difficult to propagate, and can cause clinically indistinguishable disease patterns. During 2011-2012, we used molecular methods to test adult patients in Germany with confirmed CAP for infection with these 2 pathogens. Overall, 12.3% (96/783) of samples were positive for M. pneumoniae and 3.9% (31/794) were positive for Chlamydia spp.; C. psittaci (2.1%) was detected more frequently than C. pneumoniae (1.4%). M. pneumoniae P1 type 1 predominated, and levels of macrolide resistance were low (3.1%). Quarterly rates of M. pneumoniae-positive samples ranged from 1.5% to 27.3%, showing a strong epidemic peak for these infections, but of Chlamydia spp. detection was consistent throughout the year. M. pneumoniae-positive patients were younger and more frequently female, had fewer co-occurring conditions, and experienced milder disease than did patients who tested negative. Clinicians should be aware of the epidemiology of these pathogens in CAP.
Insights
Molecular methods detected Mycoplasma pneumoniae in 12.3% of community-acquired pneumonia (CAP) patients in Germany, with a notable epidemic peak. Chlamydia spp. were less common, showing consistent detection rates throughout the year.
Area of Science:
- Infectious Diseases
- Microbiology
- Respiratory Medicine
Background:
- Mycoplasma pneumoniae and Chlamydia spp. are significant causes of community-acquired pneumonia (CAP).
- These pathogens are challenging to culture and present with similar clinical symptoms, complicating diagnosis.
- Understanding their epidemiology is crucial for effective patient management.
Purpose of the Study:
- To investigate the prevalence and epidemiological characteristics of Mycoplasma pneumoniae and Chlamydia spp. in adult CAP patients in Germany.
- To differentiate between Chlamydia psittaci and Chlamydia pneumoniae detection rates.
- To assess macrolide resistance in M. pneumoniae and identify clinical features associated with these infections.
Main Methods:
- Molecular diagnostic methods were employed to test samples from adult CAP patients in Germany between 2011 and 2012.
- Prevalence of M. pneumoniae and Chlamydia spp. was determined.
- Detection rates of C. psittaci and C. pneumoniae were compared.
- Macrolide resistance in M. pneumoniae was assessed.
- Clinical data of patients were analyzed to identify demographic and clinical differences.
Main Results:
- Mycoplasma pneumoniae was detected in 12.3% of patients, with a strong seasonal epidemic peak.
- Chlamydia spp. were detected in 3.9% of patients, with consistent year-round prevalence.
- Chlamydia psittaci (2.1%) was more prevalent than Chlamydia pneumoniae (1.4%).
- Low macrolide resistance (3.1%) was observed in M. pneumoniae.
- M. pneumoniae-positive patients were younger, more frequently female, had fewer comorbidities, and presented with milder disease.
Conclusions:
- Mycoplasma pneumoniae exhibits a distinct epidemic pattern in German CAP patients, while Chlamydia spp. show consistent prevalence.
- Molecular testing is essential for accurate diagnosis of these difficult-to-culture pathogens.
- Clinicians should consider the specific epidemiological trends and clinical presentations of M. pneumoniae and Chlamydia spp. in CAP management.
More Related Videos
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
05:46A Proinflammatory, Degenerative Organ Culture Model to Simulate Early-Stage Intervertebral Disc Disease.
Published on: February 14, 2021